Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ohoud Almadani

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
JMIR Medical Informatics|February 4, 2026
Linking Electronic Health Records for Multiple Sclerosis Research: Comparative Study of Deterministic, Probabilistic, and Machine Learning Linkage MethodsOhoud Almadani, Yasser Albogami, Adel Alrwisan
Pharmacoepidemiology and Drug Safety|November 12, 2024
Real-World Evidence of Indapamide-Induced Rhabdomyolysis: A Retrospective Analysis of Electronic Health RecordsRaseel Alroba, Almaha Alfakhri, Hisham Badreldin, et al.
Drugs - Real World Outcomes|March 16, 2026
The Effectiveness of the Safety Communication for Concurrent Benzodiazepine-Opioid Therapy: A Retrospective Real-World AnalysisRaseel Alroba, Ohoud Almadani, Dalal Alqahtani, et al.
Pharmacoepidemiology and Drug Safety|January 6, 2026
The Risk of Hypothyroidism With the Use of GLP-1 Receptor Agonists in Saudi ArabiaAlmaha Alfakhri, Ohoud Almadani, Raseel Alroba, et al.
Diabetes Research and Clinical Practice|July 6, 2024
Treatment modification patterns of glucose-lowering agents in Saudi Arabia: A retrospective real-world data analysisAlmaha Alfakhri, Ohoud Almadani, Turki Althunian, et al.
Pharmacoepidemiology and Drug Safety|May 27, 2026
Prevalent-New User Design for Biosimilar Safety Using Saudi Real-World DataOhoud Almadani, Almaha Alfakhri, Ibrahim Asiri, et al.
JCO Clinical Cancer Informatics|February 3, 2026
Evaluating the Readiness of Saudi Oncology Real-World Data for Standardization and Quality EnhancementAlmaha Alfakhri, Ohoud Almadani, Ibrahim Asiri, et al.
Drugs - Real World Outcomes|June 3, 2024
Real-World Evidence on Levetiracetam-Induced Hypokalemia: An Active Comparator Cohort StudyOhoud Almadani, Raseel Alroba, Almaha Alfakhri, et al.
BMJ Public Health|June 16, 2026
Opioid-related emergency department visits in Saudi Arabia: an interrupted time series analysis of visit patterns pre-COVID-19 and post-COVID-19Raseel Alroba, Almaha Alfakhri, Maha Aldoughaim, et al.
Therapeutic Advances in Drug Safety|September 18, 2024
Fetal exposure to isotretinoin in Saudi Arabia: a multicenter real-world data analysis from 2015 to 2020Yasser Albogami, Ohoud Almadani, Sumaya N Almohareb, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
JMIR Medical Informatics|February 4, 2026
Linking Electronic Health Records for Multiple Sclerosis Research: Comparative Study of Deterministic, Probabilistic, and Machine Learning Linkage MethodsOhoud Almadani, Yasser Albogami, Adel Alrwisan
Pharmacoepidemiology and Drug Safety|November 12, 2024
Real-World Evidence of Indapamide-Induced Rhabdomyolysis: A Retrospective Analysis of Electronic Health RecordsRaseel Alroba, Almaha Alfakhri, Hisham Badreldin, et al.
Drugs - Real World Outcomes|March 16, 2026
The Effectiveness of the Safety Communication for Concurrent Benzodiazepine-Opioid Therapy: A Retrospective Real-World AnalysisRaseel Alroba, Ohoud Almadani, Dalal Alqahtani, et al.
Pharmacoepidemiology and Drug Safety|January 6, 2026
The Risk of Hypothyroidism With the Use of GLP-1 Receptor Agonists in Saudi ArabiaAlmaha Alfakhri, Ohoud Almadani, Raseel Alroba, et al.
Diabetes Research and Clinical Practice|July 6, 2024
Treatment modification patterns of glucose-lowering agents in Saudi Arabia: A retrospective real-world data analysisAlmaha Alfakhri, Ohoud Almadani, Turki Althunian, et al.
Pharmacoepidemiology and Drug Safety|May 27, 2026
Prevalent-New User Design for Biosimilar Safety Using Saudi Real-World DataOhoud Almadani, Almaha Alfakhri, Ibrahim Asiri, et al.
JCO Clinical Cancer Informatics|February 3, 2026
Evaluating the Readiness of Saudi Oncology Real-World Data for Standardization and Quality EnhancementAlmaha Alfakhri, Ohoud Almadani, Ibrahim Asiri, et al.
Drugs - Real World Outcomes|June 3, 2024
Real-World Evidence on Levetiracetam-Induced Hypokalemia: An Active Comparator Cohort StudyOhoud Almadani, Raseel Alroba, Almaha Alfakhri, et al.
BMJ Public Health|June 16, 2026
Opioid-related emergency department visits in Saudi Arabia: an interrupted time series analysis of visit patterns pre-COVID-19 and post-COVID-19Raseel Alroba, Almaha Alfakhri, Maha Aldoughaim, et al.
Therapeutic Advances in Drug Safety|September 18, 2024
Fetal exposure to isotretinoin in Saudi Arabia: a multicenter real-world data analysis from 2015 to 2020Yasser Albogami, Ohoud Almadani, Sumaya N Almohareb, et al.
Pageof 2